| Literature DB >> 32032154 |
Lei Gao1, Yue He1, Kexin Wang1, Chen Wang1, Hanhan Wu1, Anla Hu1, Liang Ruan1, Qingli Bo1, Wenjun Chen1, Chuanlai Hu1, Li Li1, Daoming Zhang2, Tao Xia2, Shiqing Qian3, Zhining Liu4, Yi Yang5, Wanshui Yang1, Hua Wang6,7, Qihong Zhao1.
Abstract
We aimed to detect the expression of specific LncRNAs in exosomes isolated from the serum of patients with precancerous lesions and to study the effect of these serum exosomes on the activity of GES-1 cells in patients with precancerous lesions, as well as the activity of all-trans retinoic acid on GES-1 cells with or without the exosomes. Exosomes were extracted from the serum of patients with precancerous lesions and normal controls. Based on our previous sequencing results, quantitative real time-PCR was used to detect differentially expressed LncRNAs. Exosomes from the serum of patients with precancerous lesions were cocultured with GES-1 cells, and 5 μM all-trans retinoic acid was added as an intervention. Changes in cell viability and expression of LncHOXA10 were observed. Compared with the blank group, the proliferation activity of GES-1 cells cocultured with exosomes derived from the serum of patients with precancerous lesions was increased (P < 0.01), the proportion of cells in S phase was increased (P < 0.05). After adding 5 μM all-trans retinoic acid, the viability of cells decreased significantly (P < 0.01), the proportion of cells in S phase decreased significantly (P < 0.05). The expression of LncHOXA10 was decreased (P < 0.05). All-trans retinoic acid can conduct its chemopreventive effects by inhibiting the expression of LncHOXA10, thereby reducing the activity of LncHOXA10 in GES-1 cells cocultured with serum exosomes from patients with precancerous lesions.Entities:
Mesh:
Substances:
Year: 2021 PMID: 32032154 DOI: 10.1097/CEJ.0000000000000571
Source DB: PubMed Journal: Eur J Cancer Prev ISSN: 0959-8278 Impact factor: 2.497